AKKERI

Akkeri, Inc.

@akkeri_inc

US
Biotechnology Research

Overview

About Akkeri, Inc.

Akkeri is a consulting group specializing in nonclinical drug development. We provide experienced strategic advice and operational support on drug development programs to include program design, regulatory guidance, scientific & regulatory writing (IND, NDA, CTA, MAA, IB, pre-IND), due diligence, nonclinical study planning, management & monitoring, and project team participation. We have experience across modalities such as small molecules, biologics, cell & gene therapy, and vaccines for a range of therapeutic areas and routes of administration. Our consultants bring a wealth of industry experience from biotech, large pharma, CROs, and FDA. We value a strong working relationship with clients and look forward to an opportunity to partner with your team!

Headquarters

-

Website

-

Company Size

11-50 employees

Industry

Biotechnology Research

Company Type

Privately Held

Founded

2025

Specialties

Nonclinical Drug Development, Consulting, Nonclinical Consulting, Toxicology, Medical Writing, Nonclinical Study Monitoring, Nonclinical Safety Strategies, Good Laboratory Practices, Gene Therapy, Nonclinical, Regulatory Strategies, FDA Meetings, IND/NDA/BLA, Reproductive Toxicology, Risk Assessment, Preclinical Abuse Liability, Cell Therapy, Ophthalmology, Vaccines, Pharmacokinetics/Toxicokinetic, and Permissible Daily Exposure Calculation

Posts